MAIA Biotechnology (MAIA) Enterprise Value (2022 - 2026)

MAIA Biotechnology (MAIA) has reported Enterprise Value for 5 consecutive years, with $60.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 27.27% year-over-year to $60.0 million in Q2 2026; TTM through Jun 2026 was $60.0 million, a 27.27% increase from a year earlier, with the FY2025 full-year figure at $40.5 million, down 4.06% from the prior year.
• Enterprise Value was $60.0 million for Q2 2026 at MAIA Biotechnology, up from $28.9 million in the prior quarter.
• Over five years, Enterprise Value peaked at $69.6 million in Q2 2024 and troughed at $8.4 million in Q4 2023.
• A 5-year average of $37.1 million and a median of $35.7 million in 2024 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value plunged 69.59% in 2023 and surged 404.36% in 2024, its largest moves.
• Over 5 years, Enterprise Value stood at $27.5 million in 2022, then sank by 69.59% to $8.4 million in 2023, then surged by 404.36% to $42.2 million in 2024, then declined by 4.06% to $40.5 million in 2025, then soared by 48.19% to $60.0 million in 2026.
• The last three Enterprise Value figures came in at $60.0 million (Q2 2026), $28.9 million (Q1 2026), and $40.5 million (Q4 2025), per Business Quant data.